Richard Scott Struthers, President & CEO: Crinetics Pharmaceuticals CRNX Sell · Filed 23/07/13

Trade details

Type: Insider sale
Amount: $491,093.76
Shares · price: 24,384 sh · $20.14 a share
Held after: 656,421 sh
Stock: Crinetics Pharmaceuticals CRNX
Person: Richard Scott StruthersPresident & CEO
Trade date: 23/07/11
Filed: 23/07/13
Days to filing: 2 days

Sold 3.6% of holdings

Share of holding sold: 3.6%

Crinetics Pharmaceuticals trades, last 26 weeks

What else happened in Crinetics Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/06/11~23/08/10

Richard Scott Struthers's recent trades

Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$489.7K
13,196 sh
$489.7K
Filed 03/18
Traded 03/16
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$331.8K
8,785 sh
$331.8K
Filed 03/18
Traded 03/16
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$180K
4,000 sh
$180K
Filed 25/09/30
Traded 25/09/26
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$562.5K
16,463 sh
$562.5K
Filed 25/03/21
Traded 25/03/19
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$30.5K
875 sh
$30.5K
Filed 25/03/21
Traded 25/03/19

Richard Scott Struthers, CEO — sold $491.1K of Crinetics Pharmaceuticals CRNX · 3.6% of holdings · 10b5-1 plan | Whalegun